Although this result does not prove a causal relationship between MMF treatment and the downregulation of CCL2 expression, it suggests that MMF may improve SSc by inhibiting the chemokine system, providing a possible direction for the treatment of SSc and even SSc-ILD. This evidence concerns the gene CCL2 and systemic sclerosis.